Cisco
CSCO
Disney
DIS
Adobe
ADBE
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
ADPT Adaptive Biotechnologies
- 8.160
- -0.200-2.39%
Close Feb 27 16:00 ET
- 8.160
- 0.0000.00%
Post 16:33 ET
1.21BMarket Cap-7.56P/E (TTM)
8.580High8.160Low869.11KVolume8.410Open8.360Pre Close7.23MTurnover0.90%Turnover RatioLossP/E (Static)147.77MShares8.95052wk High5.95P/B790.35MFloat Cap2.28052wk Low--Dividend TTM96.86MShs Float71.250Historical High--Div YieldTTM5.02%Amplitude2.280Historical Low8.316Avg Price1Lot Size
Adaptive Biotechnologies News
Piper Sandler Sticks to Their Buy Rating for Adaptive Biotechnologies (ADPT)
Piper Sandler Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Raises Target Price to $11
BTIG Initiates Adaptive Biotechnologies(ADPT.US) With Buy Rating, Announces Target Price $10
Adaptive Biotechnologies Is Maintained at Sector Outperform by Scotiabank
Adaptive Biotechnologies Analyst Ratings
Scotiabank Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Raises Target Price to $12
Stable Performance and Strategic Guidance Support Hold Rating for Adaptive Biotechnologies
TD Cowen Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Announces Target Price $10
Analysts Offer Insights on Healthcare Companies: Adaptive Biotechnologies (ADPT) and Springworks Therapeutics (SWTX)
J.P. Morgan Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Raises Target Price to $8
Adaptive Biotechnologies Analyst Ratings
Goldman Sachs Maintains Neutral on Adaptive Biotechnologies, Raises Price Target to $7.5
Piper Sandler Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Maintains Target Price $7
Analysts Offer Insights on Healthcare Companies: Adaptive Biotechnologies (ADPT) and Teladoc (TDOC)
Adaptive Biotechnologies Analyst Ratings
BTIG Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Raises Target Price to $9
Morgan Stanley Maintains Adaptive Biotechnologies(ADPT.US) With Hold Rating, Maintains Target Price $7
Morgan Stanley Maintains Adaptive Biotechnologies(ADPT.US) With Hold Rating, Maintains Target Price $7
Balanced Hold Recommendation for Adaptive Biotechnologies Amid Positive Performance and External Challenges
Scotiabank Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Maintains Target Price $10
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.